Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.97 and traded as low as $0.74. Medicure shares last traded at $0.74, with a volume of 12,400 shares changing hands.
Medicure Stock Performance
The company has a quick ratio of 1.55, a current ratio of 1.92 and a debt-to-equity ratio of 0.01. The firm has a market cap of $7.72 million, a price-to-earnings ratio of -12.32 and a beta of 0.92. The business’s fifty day moving average is $0.84 and its two-hundred day moving average is $0.96.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings results on Monday, April 8th. The company reported ($0.10) earnings per share for the quarter. Medicure had a negative net margin of 4.17% and a negative return on equity of 4.29%. The company had revenue of $3.73 million during the quarter.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Read More
- Five stocks we like better than Medicure
- What Are Growth Stocks and Investing in Them
- MarketBeat Week in Review – 4/15 – 4/19
- Financial Services Stocks Investing
- Comprehensive Analysis of PayPal Stock
- Retail Stocks Investing, Explained
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.